Curaleaf International Expands into Czech Republic with Astrasana Pharma Partnership
March 14 2024 - 6:30AM
Business Wire
Collaboration Will Increase Access to
Medical Cannabis in the Czech Republic
Curaleaf International, part of Curaleaf Holdings (TSX:CURA) and
one of Europe's largest vertically integrated cannabis companies,
is expanding into the Czech Republic, a new market for the company,
through a new supply agreement with Astrasana Pharma s.r.o.
The Czech Republic, widely regarded as one of the most
progressive nations in Europe, legalised medical cannabis in 2013.
More recently the market has experienced significant growth, and
projections suggest that the market is set to triple by 2027,
demonstrating the potential of the industry within the country.
The partnership with Astrasana Pharma s.r.o will see Curaleaf
International’s EU-GMP flower made available to patients via
Pilulka Pharmacy, a leading healthcare provider in the region. This
collaboration underscores Curaleaf International's dedication to
providing patients with reliable access to medical cannabis
products while maintaining the highest standards of quality and
service.
Juan Pablo Martinez, Head of Curaleaf International said, "Our
partnership with Astrasana Pharma s.r.o. signifies another step
forward in the growing European medical cannabis market. By working
together, we aim to enhance access to high-quality medical cannabis
in the Czech Republic. Amidst increasing demand for medical
cannabis in Europe, this collaboration highlights our dedication to
providing reliable products and driving progress in healthcare.
Together, we're facilitating patient access and contributing to the
evolution of the medicinal cannabis industry."
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240314162472/en/
Third City PR - curaleaf@thirdcity.co.uk Cathy Farmer - 07805
754904
Curaleaf (TSX:CURA)
Historical Stock Chart
From Apr 2024 to May 2024
Curaleaf (TSX:CURA)
Historical Stock Chart
From May 2023 to May 2024